Parker Waichman LLP Represents Oregon Woman in Lawsuit Alleging Transvaginal Mesh Manufactured by American Medical Systems (AMS), Endo Pharmaceuticals Caused Injuries

Share Article

Parker Waichman LLP has filed a lawsuit on behalf of an Oregon woman who suffered substantial injuries and emotional distress, allegedly due to the defective nature of her Elevate transvaginal mesh.

News Image
The lawsuit alleges that she suffered these damages as a direct result of the Defendants’ negligent and wrongful actions.

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit alleging that a transvaginal mesh implant caused substantial injuries in an Oregon woman. The suit was filed on January 18th in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Case No. 2:13-cv-01083) where it is one of many lawsuits pending in the multidistrict litigation (MDL) entitled In Re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2325). American Medical Systems, Inc., American Medical Systems Holdings, Inc., Endo Pharmaceuticals, Inc. and Endo Health Solutions Inc. have been named as Defendants.

According to the Complaint, the Plaintiff was implanted with the Elevate transvaginal mesh in January 2011. Thereafter, she suffered substantial physical pain and suffering, emotional distress, and economic loss due to medical expenses. The lawsuit alleges that she suffered these damages as a direct result of the Defendants’ negligent and wrongful actions. Allegedly, the Defendants knew about the risks of using transvaginal mesh but did not warn the Plaintiff. Among other things, the lawsuit alleges that the mesh is defective because the material used is not inert, and can therefore react with the tissues of the body; this can cause severe complications, including organ damage, urinary problems and mesh erosion, where the device moves through the body’s tissues.

In July 2011, the U.S. Food and Drug Administration (FDA) warned that complications from transvaginal mesh are “not rare” and stated that there was no clear evidence of the benefits of using transvaginal mesh over non-mesh methods of treating pelvic organ prolapse (POP). According to the agency’s Safety Communication on the matter, the most common adverse events related to transvaginal mesh include:

  • Mesh erosion through the vagina (also called exposure, extrusion, protrusion)
  • Pain
  • Infection
  • Bleeding
  • Pain during sexual intercourse (dyspareunia)
  • Organ perforation
  • Urinary problems

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and stress urinary incontinence (SUI) surgery with mesh, please visit the firm's transvaginal mesh injury page at Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Parker Waichman LLP
Email >
Follow us on
Visit website